Monitoring response of advanced Merkel cell carcinoma to Avelumab with 18F-FDG PET/CT
Image of the Month
- 3 Downloads
- 2.Bharmal M, Marrel A, Hennessy M, Fofana F, Lambert J, Arnould B. Comparative effectiveness of avelumab versus chemotherapy in Merkel cell carcinoma: innovative use of patient insights. J Comp Eff Res. 2018. https://doi.org/10.2217/cer-2018-0048.
- 3.Esgghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for monitoring response of Merkel cell carcinoma to the novel programmed cell death ligand 1 inhibitor Avelumab. Clin Nucl Med. 2018;43:e142–4.Google Scholar
© Springer-Verlag GmbH Germany, part of Springer Nature 2018